Life sciences

We completed an analysis of healthcare claims data and found that accidental drug overdose deaths due to psychotropic and other select central nervous system medications are increasing in prevalence.

Artificial intelligence tools, such as machine learning, have the potential to improve healthcare operations, diagnosis detection and workflows.

The Inflation Reduction Act will have countless implications for all industry stakeholders and will alter the Medicare landscape in 2023 and beyond.

Regenerative and targeted therapies increase the need to accurately identify rare diseases, and increased specificity in diagnosis codes of the ICD-10 could help.

Since the start of the COVID-19 pandemic, influenza positivity rates have remained at the lowest levels documented in modern history.

Expanding the utility and consistency of existing claims-coding processes may offer a low-effort, high-value return for health economics and outcomes research.

This paper uses calendar year 2018 Medicare Advantage administrative claim data for enrollees aged 65 and older enrolled in plans with embedded dental coverage to determine the types of dental services used and the dental per…

When it comes to gene and cell therapies, there are a number of risks and benefits that payers should consider.

Gene and cell therapies are notable health care innovations that could reshape the way certain diseases are managed and treated.

This report evaluates alternative payment models that potentially could be instituted by healthcare payers and manufacturers.